Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Matveychuk, M. Numan, A. Guber, B. Chen, D. Shitrit (Kfar Saba, Israel). The role of procoagulant activity in patients with community acquired pneumonia. Eur Respir J 2012; 40: Suppl. 56, 1738

Member's Comments

No comment yet.

Related content which might interest you: The prognostic importance of plasma D-dimer levels in patients with community acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005 Condition of cellular immunity in patients with prolonged course of community acquired pneumonia Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 Phagocyte activity of blood cells and interleukin-8 at young patients with community acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 50s Year: 2004 Differences between local and systemic inflammatory response in patients with community acquired pneumonia (CAP) Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006 The general evaluation of elderly patients with community acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004 Defining stability in pneumonia and the non-responding pneumonia Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 The effect of intravenous immunoglobulin on oxygen-dependent metabolism of blood cells in patients with community acquired pneumonia Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012 The effect of intravenous immunoglobulin on active oxygen forms production in patients with community acquired pneumonia Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 Imaging patterns of bacterial community acquired pneumonia in moderately immunocompromised patients Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009 The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Using roncoleukine in basic therapy of patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 The clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia of the 3rd group Source: Eur Respir J 2007; 30: Suppl. 51, 548s Year: 2007 Increased Tpef/Te ratio reflects restrictive disorders in patients with community acquired pneumonia Source: Annual Congress 2007 - Assessing the airways: innovation, applications and pitfalls Year: 2007 Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Phagocytic ability of granulocytes and monocytes in elderly patients with community acquired pneumonia Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018